Viewing Study NCT01708161

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 12:11 PM

Ignite Modification Date: 2026-02-21 @ 11:18 PM

Study NCT ID: NCT01708161

Status: TERMINATED

Last Update Posted: 2018-09-13

First Post: 2012-09-19

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors

Sponsor: Novartis Pharmaceuticals

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Adverse Events Module Baseline Characteristics Module Participant Flow Module